Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants

2018 ◽  
Vol 21 (7) ◽  
pp. 510-515 ◽  
Author(s):  
Halit Halil ◽  
Cuneyt Tayman ◽  
Mehmet Buyuktiryaki ◽  
Nilufer Okur ◽  
Ufuk Cakır ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Neonatal Sepsis ◽  
Serum Levels ◽  
Control Group ◽  
Rapid Progression ◽  
Study Group ◽  
C Reactive Protein ◽  
Mortality And Morbidity ◽  
Interleukin 33 ◽  
Reactive Protein

Background: Neonatal sepsis is considered as the most frequent cause of death in newborns. Early diagnosis is important to reduce mortality and morbidity. The rapid progression of the disease requires proper use of biomarkers specific for prompt diagnosis and intervention. Objective: We aimed to evaluate the benefit of interleukin-33 serum levels in the diagnosis and treatment of neonatal sepsis. Method: We included 51 infants with neonatal sepsis as the main study group and 50 neonates without sepsis as the control group. Serum levels of interleukin-6, interleukin-33 and C-reactive protein were measured on the 1st, 3rd and 7th days of sepsis in the study group and on the 3rd postpartum day in the control group, respectively. Results: Serum levels of interleukin-6, interleukin-33 and C-reactive protein were significantly higher in the first day of sepsis. Serum levels of interleukin-6, interleukin-33 and C-reactive protein decreased significantly on the 3rd and the 7th days of antibiotic treatment. We found a significant relationship between interleukin-33 and C-reactive protein and between interleukin-6 and C-reactive protein on the first day of sepsis. Conclusion: Serum interleukin-33 level is up-regulated in neonatal sepsis, which might be used as a novel diagnostic marker and also a useful tool to predict prognosis in early neonatal sepsis.

scholarly journals Serum level of C-reactive protein and interleukin-6 in children with drug-resistant epilepsy

2018 ◽  
Vol 16 ◽  
pp. 205873921880816 ◽  
Author(s):  
Mohamed M Elwan ◽  
Nirmeen A Kishk ◽  
Rasha A El-Kapany ◽  
Ibrahim E Al-Ahmer ◽  
Ahmed Elkady
Keyword(s):  
Seizure Frequency ◽  
Interleukin 6 ◽  
Age Of Onset ◽  
Serum Levels ◽  
Control Group ◽  
Drug Resistant ◽  
C Reactive Protein ◽  
Mri Findings ◽  
Reactive Protein ◽  
Drug Resistant Epilepsy

There is increasing evidence that chronic inflammation affects the pathophysiology of epilepsy, especially the drug-resistant type. Drug-resistant epilepsy is a challenging condition, because of the difficulties in its management, and its unclear epileptogenesis. This study is looking at C-reactive protein (CRP) and interleukin-6 (IL-6) levels in those with drug-resistant epilepsy and the correlation of these levels with seizure frequency. Hence, 40 children with drug-resistant epilepsy were included in this study and compared with 20 healthy volunteers (as a control group). Participants were aged between 5 and 15 years. Patients were divided into two subgroups, those with daily seizures (Group A1) and those with monthly seizures (Group A2). Serum levels of CRP and IL-6 were measured in all participants. The clinical characteristics, electroencephalography, and magnetic resonance imaging (MRI) findings were then compared. CRP levels were significantly higher in Group A1, at 21.88–93.29 mg/L than both Group A2 and the control group, at 3.02–40.37 mg/L and 2.23–13.18 mg/L, P < 0.01 and P < 0.001, respectively. The IL-6 levels were also significantly higher in Group A1, at 153.60–597.80 ng/L than in both Group A2 and the control group, at 97.40–232.50 ng/L and 12.00–96.30 ng/L, P < 0.01 and P < 0.001, respectively. Significantly higher levels of CRP and IL-6 were associated with earlier age of onset ( P < 0.01), seizure frequency ( P < 0.05), and the frequency of status epilepticus ( P < 0.01). Moreover, frequent-generalized motor seizures are correlated with elevated CRP and IL-6 levels. As a result, this systemic inflammatory reaction in children may contribute to drug-resistant seizure and potentially could be used as biomarkers to be correlated with disease severity and prognosis.

Predictive values of Ischemia modified albumin in neonatal sepsis

2017 ◽  
Vol 42 (3) ◽  
Author(s):  
Berna Hekimoğlu ◽  
Yakup Aslan ◽  
Mehmet Mutlu ◽  
Ahmet Menteşe ◽  
Süleyman Caner Karahan
Keyword(s):  
Early Diagnosis ◽  
Neonatal Sepsis ◽  
Patient Population ◽  
Control Group ◽  
Study Group ◽  
C Reactive Protein ◽  
Predictive Values ◽  
Blood Samples ◽  
Ischemia Modified Albumin ◽  
Reactive Protein

AbstractObjectiveThis study aims to identify whether ischemia-modified albumin (IMA) can be used as a marker in the diagnosis of sepsis in the term patient population.MethodsIn the study group 30 sepsis patients and 30 healthy neonatal, control group, whose gestational ages were ≥38 weeks were included. Blood samples were taken for IMA levels at baseline and on the 3rd and 10th days of the treatment. The IMA values obtained were compared with those for C-reactive protein (CRP).ResultsThe baseline CRP, IMA, and adjusted IMA levels of the patients in the study group were statistically higher compared to the control group (p<0.05). IMA and adjusted IMA values measured in the study group on the 3rd and 10th days decreased gradually and significantly compared to initial levels (p<0.0001). There was a positive correlation between the baseline IMA levels and CRP values among the patients with sepsis (r: 0.371, p<0.05). The diagnostic cut-off value of IMA in term of diagnosis of the neonatal sepsis was found to be 0.644 ABSU (p<0.0001), with a sensitivity of 93.3% and specificity of 66.7%.ConclusionWe suggest that IMA can be used as a useful biomarker in the early diagnosis of neonatal sepsis.

scholarly journals Role of Serial C-reactive Protein (CRP) in Relation to Total Leucocyte Count, Platelet Count & Blood Culture for early Diagnosis of Neonatal Septicemia in Developing Countries

2015 ◽  
Vol 32 (2) ◽  
pp. 61-65
Author(s):  
Chiranjib Barua ◽  
Md Nurul Anwar ◽  
Md Shahidullah ◽  
Shahadat Hossain ◽  
Sharmila Barua ◽  
...  
Keyword(s):  
Developing Countries ◽  
Blood Culture ◽  
Early Diagnosis ◽  
Neonatal Sepsis ◽  
Leucocyte Count ◽  
Control Group ◽  
Total Leucocyte Count ◽  
C Reactive Protein ◽  
Neonatal Septicemia ◽  
Reactive Protein

Neonatal septicemia is a clinical syndrome of systemic illness accompanied by bacteremia occuring in the first 28 days of life. Neonatal septicemia is one of the major causes of neonatal death in developing countries. Early diagnosis and treatment can prevent neonatal mortality and morbidity. The present study includes: 1) usefulness of CRP (C-reactive protein), Total Leucocyte Count, Platelet Count and Blood Culture in early diagnosis of Neonatal Sepsis, 2) significance of serial CRP in diagnosis of neonatal sepsis. 3) the prognostic value of CRP in neonatal sepsis. This is a prospective study done in neonatal ward, Chittagong Medical College Hospital and carried out from January 2008 to January 2011. Sample size was 300. One hundred fifty neonates with suspected sepsis as cases and 150 healthy babies as control were enrolled in this study. Seventy two percent of cases neonates were preterm and low birth weight. Common risk factors for neonatal septicemia which were identified in this study; preterm (72%), low birth weight (72%), premature rupture membrane (60%), chorioamnionitis (26%) and maternal urinary tract infection (16%) . Out of 150 cases of suspected neonatal sepsis total 80.7%% had raised CRP, in initial sample 70.39% were CRP positive and in 2nd sample additional 9.31% case were CRP positive . In control group 91% were CRP negative. CRP was positive in 100% of culture proven sepsis. Sensitivity of CRP was 80.67% and specificity of CRP was 76.44%. Leucocytosis was observed in 7% of cases and leucopenia was found in 11% of cases. In 82 % cases leucocyte count was found normal. In control group, 95% had normal leucocyte count and 5% had leucocytosis but no leucopenia. Sensitivity of leucocyte count was 18% and specificity was 20.68%. Thrombocytopenia was found in 28% of case group. Out of 150 cases only 15.33% yielded growth of organisms in blood culture. Klebsiella was the most common pathogen isolated which was followed by E.coli and Strph. aureus. Sensitivity of blood culture was 15.33% and specificity was 100% Therefore serial CRP can be taken as alternative method for diagnosis of neonatal sepsis specially in developing countries where blood culture is not readily available.J Bangladesh Coll Phys Surg 2014; 32: 61-65

scholarly journals The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis

2014 ◽  
Vol 25 (1) ◽  
pp. 66 ◽  
Author(s):  
Fereshteh Saddadi ◽  
Sudabeh Alatab ◽  
Farahnaz Pasha ◽  
MohammadReza Ganji ◽  
Tayebeh Soleimanian
Keyword(s):  
Interleukin 6 ◽  
Serum Levels ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Effect Of Treatment

Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis

2016 ◽  
Vol 58 (2) ◽  
pp. 119-125 ◽  
Author(s):  
H. Tolga Çelik ◽  
Oytun Portakal ◽  
Şule Yiğit ◽  
Gülşen Hasçelik ◽  
Ayşe Korkmaz ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Neonatal Sepsis ◽  
C Reactive Protein ◽  
Reactive Protein

Serum Neopterin Concentration in Children with Viral Gastroenteritis

Pteridines ◽  
2010 ◽  
Vol 21 (1) ◽  
pp. 11-16 ◽  
Author(s):  
Katarzyna Plata-Nazar ◽  
Grazyna Luczak ◽  
Magdalena Gora-Gebka ◽  
Anna Liberek ◽  
Barbara Kaminska
Keyword(s):  
Blood Count ◽  
Control Group ◽  
Study Group ◽  
Viral Gastroenteritis ◽  
Adenovirus Infection ◽  
C Reactive Protein ◽  
Viral Etiology ◽  
Serum Neopterin ◽  
Reactive Protein ◽  
Neopterin Concentration

Abstract Increased neopterin concentrations are observed in many diseases in which cellular immunity is stimulated. Gastroenteritis is still a major cause of childhood morbidity and mortality worldwide. Over 75% of all cases are caused by viral infections. Therefore a non-specific, quick, sensitive, cheap and easy-to-perform marker of viral infection, such as neopterin concentration in serum, would be a cost-effective method of identifying patients with gastroenteritis into probable viral etiology and therefore it would optimize treatment and reduce inappropriate antibiotic treatment. This study evaluated whether serum neopterin concentration can be a reliable marker of viral etiology of gastroenteritis in children. The study group consisted of 67 children: 29 girls and 38 boys, aged from 0.1 to 16.1 years with symptoms of gastroenterits and with confirmed rotavirus or adenovirus infection; the control group consisted of 105 healthy children. Clinical examinations and laboratory test including whole blood count, serum C-reactive protein, procalcitonin, and creatinine concentration were conducted. The serum neopterin level was analyzed by Elisa. Serum neopterin concentration in the study group varied from 6.03 to 171 nmol/L (median 23.7 nmol/L) and it was significantly higher than in the control group (from 2.88 to 14.8 nmol/L; median 4.73 nmol/L) (P <0.001). Neopterin concentration was above the normal value (>11 nmol/L) in 58 children from the study group and only in 6 from the control group (86.6% sensitivity and 94.3% specificity). Serum neopterin concentration did not differ significantly between children with rotavirus and adenovirus infection (P = 0.47). The correlation between serum neopterin and C-reactive protein concentrations was of borderline significance (rs = 0.23, p = 0.06); and there was no correlation between serum concentrations of neopterin and procalcitonin, white blood count, lymphocytes count, monocytes count or the body temperature. Serum neopterin concentration is highly increased in children suffering from viral gastroenteritis, regardless of the virus type. When a cut-off of 11.0 nmol/L neopterin was applied, comparison yields 86.6% sensitivity and 94.3% specificity for the diagnosis of viral gastroenteritis in pediatric patients. Further studies are necessary for other etiological agents of gastroenteritis.

scholarly journals Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome

Medicine ◽  
2017 ◽  
Vol 96 (39) ◽  
pp. e8183 ◽  
Author(s):  
Jiao Wang ◽  
Lingyan Zhu ◽  
Kaixiang Hu ◽  
Yunliang Tang ◽  
Xiangxia Zeng ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Interleukin 6 ◽  
Polycystic Ovary ◽  
Serum Levels ◽  
Metformin Treatment ◽  
C Reactive Protein ◽  
Ovary Syndrome ◽  
Reactive Protein

scholarly journals Comparative Effect of Aspirin, Meloxicam and Terminalia catappa Leaf Extract on Serum Levels of Some Inflammatory Markers in Alloxan Induced Diabetic Rats

2019 ◽  
pp. 1-10
Author(s):  
Ezekiel E. Ben ◽  
Asuquo E. Asuquo ◽  
Daniel U. Owu
Keyword(s):  
Body Weight ◽  
Interleukin 6 ◽  
Leaf Extract ◽  
Serum Levels ◽  
Diabetic Rats ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Terminalia Catappa ◽  
Aqueous Leaf Extract ◽  
Anti Inflammatory

Background: The association between diabetes mellitus and inflammation is established but the use of non-steroidal anti-inflammatory drugs is not without some health risk. Aim: The study was aimed at comparing the levels of some inflammatory biomarkers in diabetic rats treated with aqueous leaf extract of Terminalia catappa, non steroidal anti-inflammatory drugs (NSAIDs) and exogenous insulin. Materials and Methods: Thirty six (36) Wistar rats were assigned to 6 groups of 6 animals each. Group 1 and 2 served as normal and diabetic controls and received orally 5ml/kg body weight of distilled water. Group 3 was diabetic treated orally with 130mg/kg body weight of aqueous leaf extract of Terminalia catappa.  And groups 4, 5 and 6 were administered orally with aspirin (30mg/kg), meloxicam (2mg/kg) and 0.75U/kg body weight of insulin subcutaneously. Diabetes was induced with intraperitoneal injection of 150mg/kg body weight of alloxan solution and diabetes confirmed after 72 hours with blood glucose levels ≥200mg/dl. The experiment lasted for 14 days and blood was collected by cardiac puncture for serum analysis of C-reactive protein, Interleukin-6 and Fibrinogen by ELISA method. Results: The results showed significant (P<0.05) increase in serum levels of C-reactive protein, Interleukin-6 and blood fibrinogen in diabetic group compared to control. These inflammatory biomarker were significantly (P<0.05) reduced by the extract, aspirin, meloxicam and insulin.  Conclusion: The reduced levels of C-reactive protein, Interleukin-6 and fibrinogen by aqueous leaf extract of Terminalia catappa was significant compared to aspirin and meloxicam. This may present the extract as a potent anti-inflammatory agent and could complement the function of insulin in diabetes treatment.

Sign in / Sign up

Export Citation Format

Share Document